
Gerostate Alpha
Developing novel therapeutics for aging and chronic disease
- Location
- San Francisco, CA, United States
- Team size
- 6 employees
- YC batch
- Summer 2018
- Status
- Shut down
- Stage
- Early stage

Developing novel therapeutics for aging and chronic disease

What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026

What they do:
AI drug discovery platform for neurotherapeutics
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$2.16M · Options · Feb 2026

What they do:
Targeting Cancer with Click Chemistry
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Empowering Mass Spec for Biotech and Beyond
Quick facts:
HQ: Atlanta, GA, United States

What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Quick facts:
HQ: Boston, MA, United States
Developing novel therapeutics for aging and chronic disease
San Francisco, CA, United States
6 employees, according to the company profile.
There are no funding rounds for Gerostate Alpha in our data.
Similar startups: Altay Therapeutics, Exin Therapeutics, and Shasqi.